摘要
目的 研究厄贝沙坦联合阿托伐他汀治疗急性心肌梗死的效果。方法 选取2010年9月~2014年1月本院收治的急性心肌梗死的患者116例,将其随机分为实验组、对照组,每组58例。对照组患者采用厄贝沙坦治疗,实验组在对照组基础上联合阿托伐他汀治疗。比较两组的治疗效果。结果 实验组的总有效率明显高于对照组,不良反应发生率明显低于对照组（P〈0.05）。结论 厄贝沙坦联合阿托伐他汀治疗急性心肌梗死,效果显著,不良反应少,具有临床推广价值。
Objective To study the effect of irbesartan combined with atorvastatin in the treatment of acute myocardial infarction. Methods 116 patients with acute myocardial infarction treated in our hospital from September 2010 to January 2014 were selected and randomly divided into the experimental group and the control group,and there were 58 cases in each group. Patients in control group were given irbesartan treatment and experimental group was given atorvastatin treatment on the basis of control group.Treatment effect between two groups was compared. Results The total effective rate of experimental group was significantly higher than that of control group,and the incidence rate of adverse reaction of experimental group was significantly lower than that of control group（P〈0.05）. Conclusion In the treatment of acute myocardial infarction,irbesartan combined with atorvastatin has a significant effect and less adverse reaction,and has clinical promotion value.
出处
《中国当代医药》
2015年第24期82-84,共3页
China Modern Medicine
